The effect of curcumin on the risk of mortality in patients with COVID-19: A systematic review and meta-analysis of randomized trials.
作者信息
Kow Chia Siang, Ramachandram Dinesh Sangarran, Hasan Syed Shahzad
机构信息
School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
出版信息
Phytother Res. 2022 Sep;36(9):3365-3368. doi: 10.1002/ptr.7468. Epub 2022 Apr 28.
Abstract
摘要
相似文献
1
The effect of curcumin on the risk of mortality in patients with COVID-19: A systematic review and meta-analysis of randomized trials.姜黄素对COVID-19患者死亡风险的影响：一项随机试验的系统评价和荟萃分析。
Phytother Res. 2022 Sep;36(9):3365-3368. doi: 10.1002/ptr.7468. Epub 2022 Apr 28.
2
Effects of Curcumin Supplementation on Inflammation and Metabolic Profiles in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.补充姜黄素对血液透析患者炎症和代谢指标的影响：一项随机对照试验的系统评价和荟萃分析
Am J Ther. 2023;30(6):e599-e603. doi: 10.1097/MJT.0000000000001545. Epub 2022 Jul 15.
3
The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials.姜黄素作为 COVID-19 患者膳食补充剂的效果：一项随机临床试验的系统评价。
Drug Discov Ther. 2022;16(1):14-22. doi: 10.5582/ddt.2022.01017.
4
Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.姜黄素补充剂对代谢综合征患者的代谢益处：系统评价和随机对照试验的荟萃分析。
Phytother Res. 2019 May;33(5):1289-1301. doi: 10.1002/ptr.6323. Epub 2019 Apr 2.
5
The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials.姜黄素补充剂对炎症和氧化应激生物标志物的影响：一项随机对照试验的系统评价和荟萃分析。
Phytother Res. 2019 Feb;33(2):253-262. doi: 10.1002/ptr.6226. Epub 2018 Nov 7.
6
Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.姜黄/姜黄素补充剂是否能改善非酒精性脂肪性肝病患者的血清丙氨酸氨基转移酶和天冬氨酸氨基转移酶水平？一项随机对照试验的系统评价和荟萃分析。
Phytother Res. 2019 Mar;33(3):561-570. doi: 10.1002/ptr.6270. Epub 2019 Jan 17.
7
The effect of curcumin supplementation on recovery following exercise-induced muscle damage and delayed-onset muscle soreness: A systematic review and meta-analysis of randomized controlled trials.姜黄素补充剂对运动引起的肌肉损伤和延迟性肌肉酸痛恢复的影响：系统评价和随机对照试验的荟萃分析。
Phytother Res. 2021 Apr;35(4):1768-1781. doi: 10.1002/ptr.6912. Epub 2020 Nov 10.
8
The effect of curcumin supplementation on circulating adiponectin: A systematic review and meta-analysis of randomized controlled trials.补充姜黄素对循环脂联素的影响：一项随机对照试验的系统评价和荟萃分析。
Diabetes Metab Syndr. 2019 Sep-Oct;13(5):2819-2825. doi: 10.1016/j.dsx.2019.07.045. Epub 2019 Jul 30.
9
The Effects of Curcumin Supplementation on Metabolic Biomarkers and Body Mass Index in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.姜黄素补充剂对非酒精性脂肪性肝病患者代谢生物标志物和体重指数的影响：一项随机对照试验的系统评价和荟萃分析。
Curr Pharm Des. 2022;28(23):1911-1925. doi: 10.2174/1381612828666220328111141.
10
Anti-inflammatory effects of oral supplementation with curcumin: a systematic review and meta-analysis of randomized controlled trials.口服姜黄素补充剂的抗炎作用：随机对照试验的系统评价和荟萃分析。
Nutr Rev. 2021 Aug 9;79(9):1043-1066. doi: 10.1093/nutrit/nuaa114.
引用本文的文献
1
Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis.姜黄素作为COVID-19中的抗病毒剂和免疫炎症调节剂：一项科学计量学分析。
Heliyon. 2023 Nov 2;9(11):e21648. doi: 10.1016/j.heliyon.2023.e21648. eCollection 2023 Nov.
2
COVID-19: Reducing the risk via diet and lifestyle.新型冠状病毒肺炎：通过饮食和生活方式降低风险。
J Integr Med. 2023 Jan;21(1):1-16. doi: 10.1016/j.joim.2022.10.001. Epub 2022 Oct 10.
本文引用的文献
1
A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients.一项三盲、安慰剂对照、随机临床试验，旨在评估含姜黄素纳米胶束对 COVID-19 患者细胞免疫反应亚型和临床结局的影响。
Phytother Res. 2021 Nov;35(11):6417-6427. doi: 10.1002/ptr.7294. Epub 2021 Sep 19.
2
Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial.口服姜黄素与胡椒碱作为辅助治疗新冠病毒病的随机临床试验
Front Pharmacol. 2021 May 28;12:669362. doi: 10.3389/fphar.2021.669362. eCollection 2021.
3
Curcumin as a Potential Treatment for COVID-19.姜黄素作为治疗新冠肺炎的一种潜在疗法。
Front Pharmacol. 2021 May 7;12:675287. doi: 10.3389/fphar.2021.675287. eCollection 2021.
4
Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?姜黄素纳米系统会成为新冠治疗试验中下一个有前景的抗病毒替代方案吗？
Biomed Pharmacother. 2021 Jul;139:111578. doi: 10.1016/j.biopha.2021.111578. Epub 2021 Apr 6.
5
Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.纳米姜黄素对轻、重症 COVID-19 患者 Th17 细胞反应的免疫调节作用。
J Cell Physiol. 2021 Jul;236(7):5325-5338. doi: 10.1002/jcp.30233. Epub 2020 Dec 28.
6
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.纳米姜黄素疗法，一种有前景的调节 COVID-19 患者炎症细胞因子的方法。
Int Immunopharmacol. 2020 Dec;89(Pt B):107088. doi: 10.1016/j.intimp.2020.107088. Epub 2020 Oct 20.
7
Curcumin, a traditional spice component, can hold the promise against COVID-19?姜黄素，一种传统的香料成分，能对抗 COVID-19 吗？
Eur J Pharmacol. 2020 Nov 5;886:173551. doi: 10.1016/j.ejphar.2020.173551. Epub 2020 Sep 12.
8
Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management.姜黄素：一种作为新冠病毒管理预防措施的神奇药物。
Indian J Clin Biochem. 2020 Jul;35(3):373-375. doi: 10.1007/s12291-020-00902-9. Epub 2020 Jun 17.
9
Potential effects of curcumin in the treatment of COVID-19 infection.姜黄素治疗 COVID-19 感染的潜在作用。
Phytother Res. 2020 Nov;34(11):2911-2920. doi: 10.1002/ptr.6738. Epub 2020 Jun 23.
10
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2：修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
Zotero 插件